Home>Topics>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
  1. AFREZZA Is A Brilliant Technology Without A Compelling Marketing Story

    Headlines

    Wed, 23 Jul 2014

    look into the history of this product, the FDA review (found here ), and the data in ..... whether the data for AFREZZA are adequate for FDA approval has now been answered (yes ..... substantially limited by the data in the FDA approved label, also known as the Prescribing

  2. UPDATE 1-U.S. FDA approves Gilead blood cancer drug Zydelig

    Headlines

    Wed, 23 Jul 2014

    July 23 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer.

  3. Celator: A Unique Drug Ratio Technology Company For Cancer

    Headlines

    Wed, 23 Jul 2014

    for prolonged exposure to the drugs without increased toxic effects. CPX-351, Celator's lead formulation, consists of FDA approved Cytarabine and Daunorubicin (1:5 ratio) and is currently in a Phase 3 trial in Acute Myeloid Leukemia (AML

  4. Amidst Ongoing Doubts, Exact Sciences Still Offers Opportunity

    Headlines

    Wed, 23 Jul 2014

    profits, though likely not as quickly as some on the Street expect. I believe these shares can trade into the high teens with an FDA approval and favorable coverage decision, and I expect the second half of this year to be a pretty active period for the company

  5. FDA approves Zydelig for three types of blood cancers

    Headlines

    Wed, 23 Jul 2014

    The U.S. regulator grants traditional approval for Gilead Sciences' ( GILD +0.4% ) Zydelig ( idelalisib ) as a treatment for chronic lymphocytic leukemia (CLL) that has relapsed. Zydelig is to used with Rituxan ( rituximab ) ( OTCQX:RHHBY +0.3% ) ( BIIB +11.6% ) in cases where Rituxan alone is ...

  6. U.S. FDA approves Gilead's blood cancer drug Zydelig

    Headlines

    Wed, 23 Jul 2014

    July 23 (Reuters) - The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday.

  7. Shire backs Hunter syndrome drug development

    Headlines

    Wed, 23 Jul 2014

    for research. ArmaGen will be responsible for early- and mid-stage development while Shire will manage the late-stage work. The product candidate, AGT-182 , has been designated an Orphan Drug by the FDA and EMA. Post your comment!

  8. New Morningstar Analyst Report for Silgan Holdings Inc

    Stock Reports

    Wed, 23 Jul 2014

    and poor execution. Many of Silgan's cans use bisphenol A as an interior lining. Although the U.S. Food and Drug Administration currently allows the use of BPA in food packaging, there have been growing concerns about its impact on

  9. Latest China Food Safety Scare Poses Risk to Yum, McDonald's, and Other Western Restaurant Companies

    Commentary

    Wed, 23 Jul 2014

    Several restaurant and food-service firms have cut ties with meat supplier OSI this week amid a China Food and Drug Administration investigation into OSI subsidiary Shanghai Husi Food for allegedly supplying expired beef and chicken to Yum Brands

  10. FDA gives thumbs up to Ryanodex

    Headlines

    Wed, 23 Jul 2014

    The FDA approves Eagle Pharmaceuticals' (NASDAQ: EGRX ) Ryanodex ( dantrolene sodium) injectable suspension for the treatment of malignant

« Prev12345Next »
Content Partners